Search Results 1141-1150 of 16036 for melatonin receptor agonists
... receptor blockers (ARBs). These patients are at high risk for progression of kidney disease, which can result in end-stage renal failure. Participation ...
About this study. The Enhanced, EHR-facilitated Cancer Symptom Control (E2C2) Pragmatic Clinical Trial will determine whether systematically assessing ...
Fluvoxamine is used to treat obsessive compulsive disorder (OCD). It belongs to a group of medicines known as selective serotonin reuptake inhibitors (SSRIs).
Brain activity measures(known as cortical excitability and inhibition) will be collected by Transcranial Magnetic Stimulation (TMS). TMS is a noninvasive (no ...
View research faculty in the Department of Molecular Pharmacology and Experimental Therapeutics at Mayo Clinic.
Zhu, Jane M.D., Ph.D. Zhu.Shizhen@mayo.edu; Associate Professor of Biochemistry and Molecular Biology; Publications. More about research at Mayo ...
The purpose of this post-approval study is to further evaluate the long-term safety and effectiveness of Medtronic DBS therapy for epilepsy on seizure ...
This study will involve in-depth, qualitative interviews with adults who have a diagnosis of NT2 (N = 15), who meet the agreed inclusion/exclusion criteria. All ...
Benztropine is used with other medicines to treat Parkinson's disease. By improving muscle control and reducing stiffness, this medicine allows more normal ...
Pomalidomide may stimulate the immune system to kill cancer cells. Drugs used in chemotherapy, such as dexamethasone, work in different ways to stop the growth ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 3 to double your impact.